The Nigeria Parkinson Disease Registry: Process, Profile, and Prospects of a Collaborative Project

Autor: Abiodun J. Kehinde, Olajumoke Oshinaike, Shyngle I. Oyakhire, SA Abubakar, Charles O. Achoru, Abiodun H Bello, Akintunde A Adebowale, Ernest O. Nwazor, Godwin Osaigbovo, Lukman Owolabi, Nosakhare Osemwegie, Emmanuel E. Obehighe, Frank Aiwansoba Imarhiagbe, Paul Olowoyo, Kolawole Wahab, Cyril O. Erameh, Musbahu Rabiu, Yakub Wilberforce Nyandaiti, Temitope Farombi, Oluwadamilola O. Ojo, Cosmas M. Nwosu, Salisu A. Balarabe, Gerald A. Onwuegbuzie, Oladunni V. Abiodun, Funlola T. Taiwo, O. S. Ekenze, Alagoma Iyagba, Babatunde Ademiluyi, Olaleye Adeniji, Ohwotemu Arigbodi, Morenikeji Komolafe, Bertha C. Ekeh, Yahaya Obiabo, Paul O Nwani, John E. Akpekpe, Franklin O Dike, E U Iwuozo, Olanike A. Odeniyi, Folajimi M. Otubogun, Osigwe P. Agabi, Babawale Arabambi, Christian E. Agu, Ifeyinwa Ani-Osheku, U. E. Williams, Mie Rizig, Njideka U Okubadejo, Yusuf A. Zubair, Francis E Odiase, Mohammed W. Ali, Michael B. Fawale, Rufus Akinyemi, Emmanuel N. Chapp‐Jumbo
Rok vydání: 2020
Předmět:
Zdroj: Movement Disorders. 35:1315-1322
ISSN: 1531-8257
0885-3185
Popis: BACKGROUND Clinical disease registries are useful for quality improvement in care, benchmarking standards, and facilitating research. Collaborative networks established thence can enhance national and international studies by generating more robust samples and credible data and promote knowledge sharing and capacity building. This report describes the methodology, baseline data, and prospects of the Nigeria Parkinson Disease Registry. METHODS This national registry was established in November 2016. Ethics approval was obtained for all sites. Basic anonymized data for consecutive cases fulfilling the United Kingdom Parkinson's Disease Brain Bank criteria (except the exclusion criterion of affected family members) are registered by participating neurologists via a secure registry website (www.parkinsonnigeria.com) using a minimal common data capture format. RESULTS The registry had captured 578 participants from 5 of 6 geopolitical zones in Nigeria by July 2019 (72.5% men). Mean age at onset was 60.3 ± 10.7 years; median disease duration (interquartile range) was 36 months (18-60.5 months). Young-onset disease (
Databáze: OpenAIRE